[Progress in the study of cyclic nucleotide phosphodiesterases]
- PMID: 8584886
[Progress in the study of cyclic nucleotide phosphodiesterases]
Abstract
There are five families of cyclic nucleotide phosphodiesterase isozymes, which have a common structure, but have different biochemical characteristics, physiologic functions and regulatory mechanisms. Various selective phosphodiesterase inhibitors may have potential uses for antiasthmatic, inotropic, vasodilative, antithrombotic and antidepressant drugs.
Similar articles
-
[Cyclic nucleotide phosphodiesterases: diversity, classification, structure and function].Acta Cient Venez. 1997;48(3):145-53. Acta Cient Venez. 1997. PMID: 9640674 Review. Spanish.
-
Regulatory mechanisms of particulate cyclic nucleotide phosphodiesterases.Adv Second Messenger Phosphoprotein Res. 1992;25:165-84. Adv Second Messenger Phosphoprotein Res. 1992. PMID: 1313258 Review. No abstract available.
-
Modulation of cyclic nucleotides and cyclic nucleotide phosphodiesterases in pancreatic islet beta-cells and intestinal L-cells as targets for treating diabetes mellitus.Curr Opin Investig Drugs. 2006 Oct;7(10):898-905. Curr Opin Investig Drugs. 2006. PMID: 17086934 Review.
-
Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1745-52. Invest Ophthalmol Vis Sci. 1999. PMID: 10393044
-
Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.Trends Pharmacol Sci. 1991 Jan;12(1):19-27. doi: 10.1016/0165-6147(91)90484-a. Trends Pharmacol Sci. 1991. PMID: 1848733 Review.